International Clinical Trial: A Bioequivalence study of a randomized, open-label, single dose, full replicated crossover design with four-period, two-treatment, and two-sequence of Ezetimibe and Atorvastatin 10/40 mg film-coated tablets relative to ATOZET (10 MG/40 MG) in healthy Thai participants under fasting condition

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (TCTR20260225007) titled 'A Bioequivalence study of a randomized, open-label, single dose, full replicated crossover design with four-period, two-treatment, and two-sequence of Ezetimibe and Atorvastatin 10/40 mg film-coated tablets relative to ATOZET (10 MG/40 MG) in healthy Thai participants under fasting condition' on Feb. 25.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Bio-innova Co., Ltd.

Condition: Healthy volunteers Bioequivalence Ezetimibe and Atorvastatin 10/40 mg film-coated tablets Bioequivalence Ezetimibe and Atorvastatin 10/40 mg film-coated tablets

Intervention: The new generic products which...